News | July 27, 2008

New Family of Neurovascular Retrievers Launched by Concentric Medical

July 28, 2008 - Concentric Medical Inc. today said it launched its “V” series of Merci Retrievers, available in multiple configurations and sizes to match patient anatomy to remove blood clots and help restore blood flow in patients who have suffered ischemic strokes.

The distal end of the latest Retriever is tightly coiled, which resists stretching and assists in dislodging clots. The proximal end of the V series retrievers is more loosely coiled, which facilitates wrapping and holding a dislodged clot. Similar to Concentric Medical’s L family of retrievers, the V series of Merci Retrievers incorporate filaments that provide an additional mechanism for securing blood clots during retrieval from the brain, the company said. The V series of Merci Retrievers will be available in diameters of 2.0, 2.5 and 3.0 millimeters.

The Merci Retriever is made with a flexible, shaped Nitinol wire that allows delivery of the retriever in linear form using standard catheterization techniques. A neurointerventionalist makes a small puncture in the groin to introduce the Merci Retriever into an artery leading to the brain. The Merci Retriever returns to its original shape when deployed in and around the blood clot in the brain.

For more information: www.concentric-medical.com


Related Content

News | Stroke

March 5, 2024 — Frequent cannabis smoking may significantly increase a person’s risk for heart attack and stroke ...

Home March 05, 2024
Home
News | Stroke

March 5, 2024 — Biosense Webster, Inc., a global leader in cardiac arrhythmia treatment and part of Johnson & Johnson ...

Home March 05, 2024
Home
News | Stroke

February 26, 2024 — Ischemic strokes are a major health burden. They occur when a blood vessel that supplies the brain ...

Home February 26, 2024
Home
News | Stroke

February 15, 2024 — Research findings in a clinical trial led by a professor at the University of Tennessee Health ...

Home February 15, 2024
Home
News | Stroke

February 13, 2024 — RapidAI, the global leader in developing Artificial Intelligence (AI) and clinical workflow ...

Home February 13, 2024
Home
News | Stroke

February 12, 2024 — VST Bio Corp. a leader in the development of innovative biologics to treat acute and chronic ...

Home February 12, 2024
Home
News | Stroke

February 9, 2024 — MIVI Neuroscience, Inc. announced the primary endpoint results of its EvaQ Trial, a prospective ...

Home February 09, 2024
Home
News | Stroke

February 7, 2024 — Medtronic announced new cost-effectiveness data from the STROKE AF clinical study, which showed that ...

Home February 07, 2024
Home
News | Stroke

February 7, 2024 — Combining brain stimulation with intense physical rehabilitation helped stroke survivors recover ...

Home February 07, 2024
Home
News | Stroke

January 15, 2024 — Larry Goldstein, M.D., chair of the University of Kentucky Department of Neurology, has been selected ...

Home January 15, 2024
Home
Subscribe Now